Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04787913
Other study ID # herdimm
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2021
Est. completion date December 2021

Study information

Verified date March 2021
Source Laval University
Contact Holly Witteman, PhD
Phone 418-656-2131
Email holly.witteman.1@ulaval.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a PhD project conducted by Ms. Hina Hakim, supervised by Dr. Holly O. Witteman, PhD, and co-supervised Dr. Daniel Reinharz, professors and researchers at the Faculty of Medicine at Laval University. The purpose of this study is to evaluate the effects of visualization conveying the concept of community immunity or herd immunity on risk perception (towards individual, family, community and vulnerable people in communities) (primary outcome) and on emotions, attitudes, knowledge, and behavioural intentions (secondary outcomes).


Description:

Visualization is a powerful communication mechanism that uses pre-attentive processing to communicate large amounts of information rapidly in understandable and compelling ways (Healey and Enns 2012). A systematic review demonstrates that there are some interventions available for conveying the concept of community immunity, and very few evaluate interventions for their effects on vaccine intentions and uptake as well as their precursors, such as knowledge, attitudes, knowledge and none on emotions (Hakim et al. 2018). The purpose of this study is to evaluate the effects of visualization conveying the concept of community immunity on risk perception (to individual, family, community and vulnerable people in communities) (primary outcome) and on emotions, attitudes, knowledge, and behavioural intentions (secondary outcomes).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 5440
Est. completion date December 2021
Est. primary completion date May 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Members of the general population in Canada - At least 18 years old - Able to provide free and informed consent - Able to read and understand French or English - Able to use a computer Exclusion Criteria: - No internet access

Study Design


Related Conditions & MeSH terms

  • Understanding of Community Immunity as a Concept

Intervention

Behavioral:
herdimm
In this visualization participants can build their own avatar representing themselves and 8 other avatars representing people around them, like their family or coworkers. Our visualization then uses these avatars in a brief narrated video explaining how herd immunity works.
guardianmeasles
A screen capture of an interactive visualization: https://www.theguardian.com/society/ng-interactive/2015/feb/05/-sp-watch-how-measles-outbreak-spreads-when-kids-get-vaccinated
theotheredmundmeasles
A gif showing measles spreading through populations with differing levels of vaccine coverage: https://imgur.com/gallery/8M7q8#J7LANQ4
sbsnewsgeneric
A video showing how herd immunity works in general: https://www.sbs.com.au/news/two-sydney-babies-too-young-to-be-vaccinated-infected-with-measles
publichealthagencycanadaflu
A video showing how herd immunity works in the context of influenza: https://www.canada.ca/fr/sante-publique/services/video/la-grippe-n-en-passez-pas-les-maux.html
robertkochgeneric
A web-based application showing how herd immunity works in general: http://rocs.hu-berlin.de/D3/herd/

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Laval University

Outcome

Type Measure Description Time frame Safety issue
Primary Risk perception 6 ad hoc questions assessing risk perception immediately after intervention or control
Secondary emotions, attitudes, knowledge, and behavioural intentions ad hoc questions and 5C scale (Betsch et al.) immediately after intervention or control